Glucocorticoid paradoxically recruits adipose progenitors and impairs lipid homeostasis and glucose transport in mature adipocytes

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Ayala Sumuano, Jorge Tonatiuh ^a,b   Velez Delvalle, Cristina ^a   Beltrán Langarica, Alicia ^a   Marsch Moreno, Meytha ^a   Hernandez Mosqueira, Claudia ^a   Kuri Harcuch, Walid ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; GLUCOCORTICOID; GLUCOSE; TRANSCRIPTOME;

ADIPOCYTE; ADIPOGENESIS; ANIMAL; ARTICLE; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; LIPID METABOLISM; METABOLISM; MOUSE; PHOSPHORYLATION; STEM CELL; TRANSPORT AT THE CELLULAR LEVEL;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; BIOLOGICAL TRANSPORT; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; CELLS, CULTURED; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOCORTICOIDS; GLUCOSE; HOMEOSTASIS; LIPID METABOLISM; MICE; PHOSPHORYLATION; STEM CELLS; TRANSCRIPTOME;

EID: 84883816458     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02573     Document Type: Article

References (50)

1. Green, H. & Kehinde, O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5, 19-27 (1975).
2. Green, H. & Kehinde, O. Formation of normally differentiated subcutaneous fat pads by an established preadipose cell line. J Cell Physiol 101, 169-171 (1979). (Pubitemid 10196616)
3. Green, H. &Meuth,M. An established pre-adipose cell line and its differentiation in culture. Cell 3, 127-133 (1974).
4. Mandrup, S., Loftus, T. M., MacDougald, O. A., Kuhajda, F. P. & Lane, M. D. Obese gene expression at in vivo levels by fat pads derived from s.c. implanted 3T3-F442A preadipocytes. Proc Natl Acad Sci U S A 94, 4300-4305 (1997). (Pubitemid 27194236)
5. Green, H. & Kehinde, O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7, 105-113 (1976).
6. Kuri-Harcuch, W. & Green, H. Adipose conversion of 3T3 cells depends on a serum factor. Proc Natl Acad Sci U S A 75, 6107-6109 (1978). (Pubitemid 9093671)
7. Gamou, S. & Shimizu, N. Adipocyte differentiation of 3T3-L1 cells in serum-free hormone-supplemented media: effects of insulin and dihydroteleocidin B. Cell Struct Funct 11, 21-30 (1986). (Pubitemid 17222937)
8. Rubin, C. S., Hirsch, A., Fung, C. & Rosen, O. M. Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells. J Biol Chem 253, 7570-7578 (1978).
9. Diaz-Velasquez, C. E., Castro-Munozledo, F. & Kuri-Harcuch,W. Staurosporine rapidly commits 3T3-F442A cells to the formation of adipocytes by activation of GSK-3beta and mobilization of calcium. J Cell Biochem 105, 147-157 (2008).
10. Ayala-Sumuano, J. T. et al. Srebf1a is a key regulator of transcriptional control for adipogenesis. Sci Rep 1, 178 (2011).
11. Masuzaki, H. et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166-2170 (2001). (Pubitemid 33150673)
12. Yu,C. Y. et al.Genome-wide analysis of glucocorticoid receptor binding regions in adipocytes reveal gene network involved in triglyceride homeostasis. PLoS One 5, e15188 (2010).
13. Arnaldi, G. et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88, 5593-5602 (2003). (Pubitemid 38033020)
14. Christ-Crain, M. et al. AMP-activated protein kinase mediates glucocorticoidinduced metabolic changes: a novel mechanism in Cushing's syndrome. FASEB J 22, 1672-1683 (2008). (Pubitemid 351811445)
15. Colao, A. et al. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84, 2664-2672 (1999). (Pubitemid 30641990)
16. Hamm, J. K., el Jack, A. K., Pilch, P. F. & Farmer, S. R. Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake. Ann N Y Acad Sci 892, 134-145 (1999).
17. Wang, L., Shao, Y. Y. & Ballock, R. T. Peroxisome Proliferator-Activated Receptor-gamma Promotes Adipogenic Changes in Growth Plate Chondrocytes In Vitro. PPAR Res 2006, 67297 (2006).
18. Yamanouchi, K. et al. Both PPARgamma and C/EBPalpha are sufficient to induce transdifferentiation of goat fetal myoblasts into adipocytes. J Reprod Dev 53, 563-572 (2007). (Pubitemid 47052581)
19. Cao, Z., Umek, R. M. & McKnight, S. L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5, 1538-1552 (1991). (Pubitemid 21906060)
20. Kim, J. B.&Spiegelman, B. M. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 10, 1096-1107 (1996). (Pubitemid 26152851)
21. Tang, Q. Q., Zhang, J. W. & Daniel Lane, M. Sequential gene promoter interactions of C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis. Biochem Biophys Res Commun 319, 235-239 (2004).
22. Tang, Q. Q., Otto, T. C. & Lane, M. D. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci U S A 100, 850-855 (2003). (Pubitemid 36183919)
23. Tang, Q. Q., Otto, T. C. & Lane, M. D. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci U S A 100, 44-49 (2003). (Pubitemid 36078027)
24. Tang, Q. Q. et al. Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proc Natl Acad Sci U S A 102, 9766-9771 (2005).
25. Bertagna, X., Bertagna, C., Luton, J.-P., Husson, J.-M. & Girard, F. The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in Man. J Clin Endocrinol Metab 59, 25-28 (1984). (Pubitemid 14087519)
26. Hung, S. H. et al. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferatoractivated receptor-gamma pathway. Life Sci 82, 561-569 (2008).
27. Mendoza-Figueroa, T., Hernandez, A., De Lourdes Lopez, M. & Kuri-Harcuch, W. Intracytoplasmic triglyceride accumulation produced by dexamethasone in adult rat hepatocytes cultivated on 3T3 cells. Toxicology 52, 273-286 (1988).
28. Rockall, A. G. et al. Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol 149, 543-548 (2003). (Pubitemid 38054698)
29. Bujalska, I. J., Kumar, S. & Stewart, P. M. Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349, 1210-1213 (1997). (Pubitemid 27190044)
30. Reincke, M. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29, 43-56 (2000). (Pubitemid 30151888)
31. Wang, F. S., Ko, J. Y., Yeh, D. W., Ke, H. C. &Wu, H. L. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss. Endocrinology 149, 1793-1801 (2008).
32. Masuzaki, H. et al. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab 82, 2542-2547 (1997). (Pubitemid 27337870)
33. Barahona, M. J. et al. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome. J Clin Endocrinol Metab 94, 3365-3371 (2009).
34. de Ferranti, S. & Mozaffarian, D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 54, 945-955 (2008). (Pubitemid 351793400)
35. Skillington, J., Choy, L. & Derynck, R. Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol 159, 135-146 (2002). (Pubitemid 35191525)
36. Park, B. H., Qiang, L. & Farmer, S. R. Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol Cell Biol 24, 8671-8680 (2004). (Pubitemid 39245086)
37. Gerber, A. N.,Masuno, K. & Diamond, M. I. Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening. Proc Natl Acad Sci U S A 106, 4929-4934 (2009).
38. Feldman, B. J., Streeper, R. S., Farese Jr, R. V. & Yamamoto, K. R. Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci U S A 103, 15675-15680 (2006). (Pubitemid 44625651)
39. Kim, J. B., Wright, H. M., Wright, M. & Spiegelman, B. M. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci U S A 95, 4333-4337 (1998). (Pubitemid 28207912)
40. Amemiya-Kudo, M. et al. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J Lipid Res 43, 1220-1235 (2002). (Pubitemid 34988170)
41. Shimomura, I., Shimano, H., Horton, J. D., Goldstein, J. L. & Brown, M. S. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 99, 838-845 (1997). (Pubitemid 27123619)
42. Diamant, S.& Shafrir, E. Modulation of the activity of insulin-dependent enzymes of lipogenesis by glucocorticoids. Eur J Biochem 53, 541-546 (1975).
43. Niu, C. S., Yeh, C. H., Yeh, M. F. & Cheng, J. T. Increase of adipogenesis by ginsenoside (Rh2) in 3T3-L1 cell via an activation of glucocorticoid receptor. Horm Metab Res 41, 271-276 (2009).
44. Wu, Z. et al. Cross-Regulation of C/EBPalpha and PPARgamma Controls the Transcriptional Pathway of Adipogenesis and Insulin Sensitivity. Mol Cell 3, 151-158 (1999). (Pubitemid 29292616)
45. Weyer, C. et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86, 1930-1935 (2001). (Pubitemid 32472900)
46. Rentsch, J., Levens, N. & Chiesi, M. Recombinant ob-gene product reduces food intake in fasted mice. Biochem Biophys Res Commun 214, 131-136 (1995).
47. de Oliveira, C. et al. High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations. Lipids Health Dis 10, 11 (2011).
48. Morikawa, M., Green, H. & Lewis, U. J. Activity of human growth hormone and related polypeptides on the adipose conversion of 3T3 cells. Mol Cell Biol 4, 228-231 (1984). (Pubitemid 14164065)
49. Ramirez-Zacarias, J. L., Castro-Munozledo, F. & Kuri-Harcuch, W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 97, 493-497 (1992).
50. Pairault, J. & Green, H. A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker. Proc Natl Acad Sci U S A 76, 5138-5142 (1979). (Pubitemid 10231833)